Page last updated: 2024-09-05

tolvaptan and rifampin

tolvaptan has been researched along with rifampin in 4 studies

Compound Research Comparison

Studies
(tolvaptan)
Trials
(tolvaptan)
Recent Studies (post-2010)
(tolvaptan)
Studies
(rifampin)
Trials
(rifampin)
Recent Studies (post-2010) (rifampin)
96717278620,4681,4996,552

Protein Interaction Comparison

ProteinTaxonomytolvaptan (IC50)rifampin (IC50)
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.949
Caspase-1Homo sapiens (human)8.319
Alpha-synucleinHomo sapiens (human)7.1
Enoyl-[acyl-carrier-protein] reductase [NADH]Mycobacterium tuberculosis H37Rv0.03
DNA-directed RNA polymerase subunit betaMycobacterium tuberculosis H37Rv0.01
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)1.5
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)1.5

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bricmont, P; Mallikaarjun, S; Shoaf, SE1
Behr, J; Dietrich, JW; Heyer, CM; Knoop, H; Knoop, U; Kuert, S; Roggenland, D; Suermann, M1

Reviews

1 review(s) available for tolvaptan and rifampin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for tolvaptan and rifampin

ArticleYear
Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non-peptide AVP antagonist in healthy subjects.
    British journal of clinical pharmacology, 2012, Volume: 73, Issue:4

    Topics: 14-alpha Demethylase Inhibitors; Adolescent; Adult; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Female; Humans; Ketoconazole; Male; Middle Aged; Rifampin; Tolvaptan; Urination; Young Adult

2012

Other Studies

2 other study(ies) available for tolvaptan and rifampin

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Syndrome of inadequate antidiuretic hormone secretion in pulmonary tuberculosis - a therapeutic challenge.
    Pneumologie (Stuttgart, Germany), 2013, Volume: 67, Issue:4

    Topics: Antibiotics, Antitubercular; Benzazepines; Combined Modality Therapy; Diet, Sodium-Restricted; Drug Interactions; Female; Fluid Therapy; Humans; Inappropriate ADH Syndrome; Middle Aged; Rifampin; Syndrome; Tolvaptan; Treatment Failure; Tuberculosis, Pulmonary

2013